Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis Jan 9, 2026 06:01AM
Kezar Life Sciences Reports Third Quarter 2025 Financial Results Nov 12, 2025 04:01PM
Kezar Life Sciences explores strategic alternatives after FDA setback Oct 16, 2025 04:05PM
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis and Plans to Explore Strategic Alternatives Oct 16, 2025 04:05PM
TD Cowen Reiterates Buy Rating on Kezer Life Sciences (KZR) Oct 1, 2024 07:49AM


Aug 14, 2024 02:16PM TD Cowen Reiterates Buy Rating on Kezer Life Sciences (KZR)
Feb 28, 2024 04:01PM Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference
Mar 1, 2023 04:01PM Kezar Life Sciences to Participate in the Cowen 43rd Annual Health Care Conference
Nov 10, 2022 04:01PM Kezar Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
Aug 11, 2022 04:01PM Kezar Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
May 12, 2022 04:01PM Kezar Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
Mar 2, 2022 07:00AM Kezar Life Sciences to Participate in Cowen 42nd Annual Health Care Conference
Aug 12, 2021 04:02PM Kezar Life Sciences Reports Second Quarter Financial Results and Provides Business Updates
May 12, 2021 04:01PM Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates
Feb 25, 2021 04:01PM Kezar Life Sciences to Participate at Cowen 41st Annual Virtual Health Care Conference
Jun 8, 2020 08:48PM Kezar Announces Pricing of a Public Offering of $46.7 million of Common Stock and Pre-Funded Warrants
Jun 8, 2020 06:01AM Kezar Life Sciences (KZR) Announces Proposed Common Share Offering
Jun 8, 2020 06:00AM Kezar Announces Proposed Public Offering of Common Stock
Feb 26, 2020 04:01PM Kezar Life Sciences to Present at Cowen and Company’s 40th Annual Healthcare Conference
Feb 26, 2020 04:01PM Kezar Life Sciences to Present at Cowen and Company’s 40th Annual Healthcare Conference
Feb 4, 2020 05:50PM Kezar Announces Closing of $56.8 Million Public Offering of Common Stock and Pre-Funded Warrants
Feb 4, 2020 05:50PM Kezar Announces Closing of $56.8 Million Public Offering of Common Stock and Pre-Funded Warrants
Jan 31, 2020 08:13AM Kezar Life Sciences (KZR) Prices $49.4 Million Public Offering of Common Stock and Pre-Funded Warrants
Jan 31, 2020 08:12AM Kezar Announces Pricing of $49.4 Million Public Offering of Common Stock and Pre-Funded Warrants
Jan 31, 2020 08:12AM Kezar Announces Pricing of $49.4 Million Public Offering of Common Stock and Pre-Funded Warrants
Jan 30, 2020 04:32PM Kezar Life Sciences (KZR) Announces Proposed Common Share Offering
Jan 30, 2020 04:01PM Kezar Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Mar 5, 2019 08:00AM Kezar Life Sciences to Present at the Cowen and Company 39th Annual Health Care Conference
Mar 5, 2019 08:00AM Kezar Life Sciences to Present at the Cowen and Company 39th Annual Health Care Conference
Jul 16, 2018 05:42AM Cowen Starts Kezer Life Sciences (KZR) at Outperform
Jun 25, 2018 04:05PM Kezar Life Sciences Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
Jun 21, 2018 11:43AM Kezar Life Sciences (KZR) IPO Opens 33% Higher
Jun 21, 2018 06:34AM Kezar Life Sciences, Inc. (KZR) Prices 5M Share IPO at $15/Sh
Jun 20, 2018 08:05PM Kezar Life Sciences Announces Pricing of Initial Public Offering